Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cara Therapeutics
(NQ:
CARA
)
0.3388
+0.0151 (+4.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cara Therapeutics
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels
June 08, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Economy
Exposures
COVID-19
Cannabis
Economy
Cara Therapeutics: Return On Capital Employed Insights
June 03, 2021
During Q1, Cara Therapeutics (NASDAQ:CARA) brought in sales totaling $1.94 million. However, earnings decreased 130.09%, resulting in a loss of $23.56 million. Cara Therapeutics...
Via
Benzinga
Is Cara Therapeutics a Buy for Summer 2021?
May 29, 2021
The future of this troubled clinical-stage biotech rests on a single drug candidate that management hopes will treat an extremely common condition.
Via
The Motley Fool
Stocks That Hit 52-Week Highs On Friday
April 09, 2021
During the morning session on Friday, 178 stocks hit new 52-week highs. Noteworthy Points: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to set...
Via
Benzinga
Is Cara Therapeutics a Buy?
May 23, 2021
Maybe, if you're itching to speculate.
Via
The Motley Fool
Cannabis Stock Gainers And Losers From May 11, 2021
May 11, 2021
GAINERS: Claritas Pharmaceuticals (...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cara Therapeutics Inc (CARA) Q1 2021 Earnings Call Transcript
May 10, 2021
CARA earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Cara Therapeutics: Q1 Earnings Insights
May 10, 2021
Shares of Cara Therapeutics (NASDAQ:CARA) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 24.19% year over year...
Via
Benzinga
Cannabis Stock Gainers And Losers From April 30, 2021
April 30, 2021
GAINERS: Rhinomed (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
May 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...
Via
Benzinga
Exposures
COVID-19
Product Safety
Stocks That Hit 52-Week Lows On Monday
May 10, 2021
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT)....
Via
Benzinga
Cannabis Stock Gainers And Losers From April 29, 2021
April 29, 2021
GAINERS: RIV Capital (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
65 Biggest Movers From Yesterday
April 30, 2021
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs. Takung Art Co., Ltd. (...
Via
Benzinga
Mid-Afternoon Market Update: Dow Gains 175 Points; JAKKS Pacific Shares Climb After Q1 Results
April 29, 2021
Toward the end of trading Thursday, the Dow traded up 0.52% to 33,995.76 while the NASDAQ rose 0.13% to 14,069.67. The S&P also rose, gaining 0.50% to 4,204.22. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Gives Back Gains Amid Profit-Taking Spree
April 29, 2021
The major benchmarks are modestly higher this afternoon, as investors move to take profits following blowout earnings reports from Apple and Facebook.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Mid-Day Market Update: Nasdaq Turns Lower; Galera Therapeutics Shares Surge
April 29, 2021
Midway through trading Thursday, the Dow traded up 0.14% to 33,868.84 while the NASDAQ fell 0.33% to 14,004.20. The S&P also rose, gaining 0.15% to 4,189.46. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Cara Therapeutics Stock Is Crashing Today
April 29, 2021
The company reported disappointing results from a phase 2 study.
Via
The Motley Fool
Mid-Morning Market Update: Markets Open Higher; McDonald's Profit Beats Estimates
April 29, 2021
Following the market opening Thursday, the Dow traded up 0.23% to 33,899.83 while the NASDAQ rose 0.25% to 14,086.11. The S&P also rose, gaining 0.49% to 4,203.60. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
54 Stocks Moving In Thursday's Mid-Day Session
April 29, 2021
Gainers Willamette Valley Vineyards, Inc. (NASDAQ: WVVI) climbed 40.5% to $14.39. Dolphin Entertainment, Inc. (NASDAQ: DLPN) shares gained 23.1% to $14.14. Dolphin Entertainment...
Via
Benzinga
Cara Therapeutics' Stock Plummets As Korsuva Flunks In Mid-Stage Atopic Dermatitis Study
April 29, 2021
Cara Therapeutics Inc (NASDAQ: CARA) shares dive after as investors react to topline results from its KARE Phase 2 trial evaluating oral Korsuva (...
Via
Benzinga
Cannabis Stock Gainers And Losers From April 23, 2021
April 23, 2021
GAINERS: Tetra Bio Pharma (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
Cannabis Stock Gainers And Losers From April 19, 2021
April 19, 2021
GAINERS: General Cannabis (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From April 14, 2021
April 14, 2021
GAINERS: Claritas Pharmaceuticals (...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
April 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 6) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
51 Biggest Movers From Yesterday
April 07, 2021
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the company priced its IPO at $4 per share. Romeo Power, Inc. (NYSE: RMO) climbed 59.6...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.